Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CervoMed Inc.

    NASDAQ: CRVO · Real-Time Price · USD
    6.24
    -0.87 (-12.17%)
    At close: Jun 27, 2025, 3:59 PM
    6.15
    -1.44%
    After-hours: Jun 27, 2025, 05:48 PM EDT

    CervoMed Statistics

    Share Statistics

    CervoMed has 8.7M shares outstanding. The number of shares has increased by 5.44% in one year.

    Shares Outstanding

    n/a
    		 8.7M

    Shares Change (YoY)

    n/a
    		 5.44%

    Shares Change (QoQ)

    n/a
    		 5.44%

    Owned by Institutions (%)

    n/a
    		 15.73%

    Shares Floating

    n/a
    		 5.64M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,979

    FTD / Avg. Volume

    n/a
    		 0.45%

    Short Selling Information

    The latest short interest is 279.02K, so 3.21% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 279.02K

    Short % of Shares Out

    n/a
    		 3.21%

    Short % of Float

    n/a
    		 4.81%

    Short Ratio (days to cover)

    n/a
    		 1.77

    Valuation Ratios

    The PE ratio is -1.16 and the forward PE ratio is -3.84. CervoMed's PEG ratio is -0.01.

    PE Ratio

    n/a
    		 -1.16

    Forward PE

    n/a
    		 -3.84

    PS Ratio

    n/a
    		 1.94

    Forward PS

    n/a
    		 3.4

    PB Ratio

    n/a
    		 0.48

    P/FCF Ratio

    n/a
    		 -1.14

    PEG Ratio

    n/a
    		 -0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for CervoMed.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 11.11, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 11.11

    Quick Ratio

    n/a
    		 11.11

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $649,200

    Profits Per Employee

    n/a
    		 $-1,086,066.67

    Employee Count

    n/a
    		 15

    Asset Turnover

    n/a
    		 0.23

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -58.65% in the last 52 weeks. The beta is -0.74, so CervoMed's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.74

    52-Week Price Change

    n/a
    		 -58.65%

    50-Day Moving Average

    n/a
    		 8.33

    200-Day Moving Average

    n/a
    		 8.11

    Relative Strength Index (RSI)

    n/a
    		 43.61

    Average Volume (20 Days)

    n/a
    		 443,358

    Income Statement

    In the last 12 months, CervoMed had revenue of 9.74M and earned -16.29M in profits. Earnings per share was -2.02.

    Revenue

    n/a
    		 9.74M

    Gross Profit

    n/a
    		 -9.06M

    Operating Income

    n/a
    		 -18.23M

    Net Income

    n/a
    		 -16.29M

    EBITDA

    n/a
    		 -18.23M

    EBIT

    n/a
    		 -18.23M

    Earnings Per Share (EPS)

    n/a
    		 -2.02
    Full Income Statement

    Balance Sheet

    The company has 9M in cash and 0 in debt, giving a net cash position of 9M.

    Cash & Cash Equivalents

    n/a
    		 9M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -70.73M

    Total Assets

    n/a
    		 38.58M

    Working Capital

    n/a
    		 36.72M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -16.53M and capital expenditures 0, giving a free cash flow of -16.53M.

    Operating Cash Flow

    n/a
    		 -16.53M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -16.53M

    FCF Per Share

    n/a
    		 -2.05
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -187.18% and -167.29%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -187.18%

    Pretax Margin

    n/a
    		 -167.29%

    Profit Margin

    n/a
    		 -167.29%

    EBITDA Margin

    n/a
    		 -187.18%

    EBIT Margin

    n/a
    		 -187.17%

    FCF Margin

    n/a
    		 -169.76%

    Dividends & Yields

    CRVO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CRVO is $17.5, which is 146.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $17.5

    Price Target Difference

    n/a
    		 146.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 17, 2023. It was a backward split with a ratio of 2:3.

    Last Split Date

    n/a
    		 Aug 17, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 2:3

    Scores

    Altman Z-Score

    n/a
    		 7.11

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist